Literature DB >> 19640730

Human cancer cells have specifically lost the ability to induce the synergistic state caused by tumor necrosis factor plus interferon-beta.

Eric Bartee1, Grant McFadden.   

Abstract

Tumor necrosis factor (TNF) and the members of the interferon (IFN) family are major inducible cytokines that function to counteract viral infections or cellular transformation. Recently, our lab has characterized a novel antiviral state which is induced in primary human fibroblasts by co-treatment with TNF plus IFNbeta. Here, we demonstrate that this synergistic state is both antiviral and cytostatic for primary human cells. Significantly, we observed that a wide spectrum of transformed human cancer cells have universally lost the ability to induce the TNF/IFNbeta synergistic state, as defined by three separate criteria. We hypothesize that the ability to induce the TNF/IFNbeta synergistic state is a unique feature of primary cells and is incompatible with cellular immortalization and/or transformation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19640730      PMCID: PMC4376283          DOI: 10.1016/j.cyto.2009.06.006

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  14 in total

1.  Studies in the epidemiology of infectious myxomatosis of rabbits. VI. The experimental introduction of the European strain of myxoma virus into Australian wild rabbit populations.

Authors:  F FENNER; W E POOLE; I D MARSHALL; A L DYCE
Journal:  J Hyg (Lond)       Date:  1957-06

2.  Role of the serine-threonine kinase PAK-1 in myxoma virus replication.

Authors:  J B Johnston; John W Barrett; Wen Chang; Che-Sheng Chung; Wei Zeng; Jennefer Masters; Melissa Mann; Fuan Wang; Jingxin Cao; Grant McFadden
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

3.  Tumor necrosis factor acts synergistically with autocrine interferon-beta and increases interferon-beta mRNA levels in human fibroblasts.

Authors:  L F Reis; T Ho Lee; J Vilcek
Journal:  J Biol Chem       Date:  1989-10-05       Impact factor: 5.157

4.  TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes.

Authors:  Anna Yarilina; Kyung-Hyun Park-Min; Taras Antoniv; Xiaoyu Hu; Lionel B Ivashkiv
Journal:  Nat Immunol       Date:  2008-03-16       Impact factor: 25.606

Review 5.  Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancer.

Authors:  Marianne M Stanford; Grant McFadden
Journal:  Expert Opin Biol Ther       Date:  2007-09       Impact factor: 4.388

Review 6.  Immune responses to myxoma virus.

Authors:  Peter Kerr; Grant McFadden
Journal:  Viral Immunol       Date:  2002       Impact factor: 2.257

7.  The addition of tumor necrosis factor plus beta interferon induces a novel synergistic antiviral state against poxviruses in primary human fibroblasts.

Authors:  Eric Bartee; Mohamed R Mohamed; M Cecilia Lopez; Henry V Baker; Grant McFadden
Journal:  J Virol       Date:  2008-10-29       Impact factor: 5.103

8.  Antitumor synergism between recombinant human tumor necrosis factor and recombinant human interferon-r.

Authors:  N Watanabe; Y Niitsu; N Yamauchi; H Umeno; H Sone; H Neda; I Urushizaki
Journal:  J Biol Response Mod       Date:  1988-02

9.  RIG-I mediates the co-induction of tumor necrosis factor and type I interferon elicited by myxoma virus in primary human macrophages.

Authors:  Fuan Wang; Xiujuan Gao; John W Barrett; Qing Shao; Eric Bartee; Mohamed R Mohamed; Masmudur Rahman; Steve Werden; Timothy Irvine; Jingxin Cao; Gregory A Dekaban; Grant McFadden
Journal:  PLoS Pathog       Date:  2008-07-11       Impact factor: 6.823

Review 10.  Tumor necrosis factor and interferon: cytokines in harmony.

Authors:  Eric Bartee; Mohamed R Mohamed; Grant McFadden
Journal:  Curr Opin Microbiol       Date:  2008-07-01       Impact factor: 7.934

View more
  35 in total

1.  Type 1 IFN-independent activation of a subset of interferon stimulated genes in West Nile virus Eg101-infected mouse cells.

Authors:  Joanna A Pulit-Penaloza; Svetlana V Scherbik; Margo A Brinton
Journal:  Virology       Date:  2012-02-03       Impact factor: 3.616

2.  Oncolytic Poxviruses.

Authors:  Winnie M Chan; Grant McFadden
Journal:  Annu Rev Virol       Date:  2014-09-01       Impact factor: 10.431

3.  Oncolytic viruses: an approved product on the horizon?

Authors:  John Bell
Journal:  Mol Ther       Date:  2010-02       Impact factor: 11.454

4.  Oncolytic virotherapy for ovarian cancer.

Authors:  Shoudong Li; Jessica Tong; Masmudur M Rahman; Trevor G Shepherd; Grant McFadden
Journal:  Oncolytic Virother       Date:  2012-08

Review 5.  Oncolytic viral purging of leukemic hematopoietic stem and progenitor cells with Myxoma virus.

Authors:  Masmudur M Rahman; Gerard J Madlambayan; Christopher R Cogle; Grant McFadden
Journal:  Cytokine Growth Factor Rev       Date:  2010-03-07       Impact factor: 7.638

6.  Oncolytic virotherapy for small-cell lung cancer induces immune infiltration and prolongs survival.

Authors:  Patrick Kellish; Daniil Shabashvili; Masmudur M Rahman; Akbar Nawab; Maria V Guijarro; Min Zhang; Chunxia Cao; Nissin Moussatche; Theresa Boyle; Scott Antonia; Mary Reinhard; Connor Hartzell; Michael Jantz; Hiren J Mehta; Grant McFadden; Frederic J Kaye; Maria Zajac-Kaye
Journal:  J Clin Invest       Date:  2019-04-29       Impact factor: 14.808

Review 7.  The immunoregulatory properties of oncolytic myxoma virus and their implications in therapeutics.

Authors:  Jia Liu; Sonia Wennier; Grant McFadden
Journal:  Microbes Infect       Date:  2010-09-09       Impact factor: 2.700

8.  Histological evaluation of intratumoral myxoma virus treatment in an immunocompetent mouse model of melanoma.

Authors:  Rosalinda A Doty; Jia Liu; Grant McFadden; Edward J Roy; Amy L MacNeill
Journal:  Oncolytic Virother       Date:  2013-01

9.  Myxoma and vaccinia viruses bind differentially to human leukocytes.

Authors:  Winnie M Chan; Eric C Bartee; Jan S Moreb; Ken Dower; John H Connor; Grant McFadden
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

10.  Systems-level comparison of host-responses elicited by avian H5N1 and seasonal H1N1 influenza viruses in primary human macrophages.

Authors:  Suki M Y Lee; Jennifer L Gardy; C Y Cheung; Timothy K W Cheung; Kenrie P Y Hui; Nancy Y Ip; Y Guan; Robert E W Hancock; J S Malik Peiris
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.